Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Virtu Financial Inc. Class A Common Stock (VIRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Virtu Financial Inc. Class A Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Virtu Financial Inc. Class A Common Stock trades at $57.56 (market cap $5.19B). The key difference: Virtu Financial Inc. Class A Common Stock is far larger — about 3× Nuvation Bio Inc. Class A Common Stock's market cap, and Virtu Financial Inc. Class A Common Stock pays a 1.63% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Virtu Financial Inc. Class A Common Stock for 0 Days on average.
| NUVB | VIRT | |
|---|---|---|
Market Cap | $1.71B | $5.19B |
Volume | 5,448,712 | 1,186,043 |
Sector | Health | Financials |
52-Week High | $9.54 | $67.93 |
52-Week Low | $3.41 | $32.53 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.30B | $14.90B |
Dividend Yield | — | 1.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Virtu Financial Inc. Class A Common Stock
Virtu Financial provides technology-enabled market-making and execution services. Its platforms help institutional, retail, and other market participants trade across global financial markets.
Read more on VIRT →
